Publicaciones en colaboración con investigadores/as de University of Freiburg (14)

2024

  1. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells

    Science Immunology, Vol. 9, Núm. 91

  2. Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation

    Blood, Vol. 143, Núm. 10, pp. 872-881

2022

  1. The role of the different CD3γ domains in TCR expression and signaling

    Frontiers in Immunology, Vol. 13

2021

  1. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 2, pp. 520-531

  2. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

    Journal of Allergy and Clinical Immunology, Vol. 148, Núm. 5, pp. 1332-1341.e5

2020

  1. Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations

    Journal of Allergy and Clinical Immunology, Vol. 146, Núm. 4, pp. 901-911

2019

  1. Increased proportions of γδ T lymphocytes in atypical SCID associate with disease manifestations

    Clinical Immunology, Vol. 201, pp. 30-34

2017

  1. A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis

    Journal of Allergy and Clinical Immunology, Vol. 139, Núm. 4, pp. 1302-1310.e4

2014

  1. The CD3 conformational change in the γδ T cell receptor is not triggered by antigens but can be enforced to enhance tumor killing

    Cell Reports, Vol. 7, Núm. 5, pp. 1704-1715

2012

  1. RecX Facilitates Homologous Recombination by Modulating RecA Activities

    PLoS Genetics, Vol. 8, Núm. 12

2011

  1. A leaky mutation in CD3D differentially affects αβ and γδ T cells and leads to a Tαβ- Tγδ + B + NK + human SCID

    Journal of Clinical Investigation, Vol. 121, Núm. 10, pp. 3872-3876

2010

  1. From structure to disease: Differential cd3 usage in the human and mouse t cell antigen receptor determines the impact of CD3 deficiencies on T cell development

    Advances in Genetics Research (Nova Science Publishers, Inc.), pp. 173-192

2008

  1. Differential antibody binding to the surface αβTCR·CD3 complex of CD4+ and CD8+ T lymphocytes is conserved in mammals and associated with differential glycosylation

    International Immunology, Vol. 20, Núm. 10, pp. 1247-1258

2007

  1. Different composition of the human and the mouse γδ T cell receptor explains different phenotypes of CD3γ and CD3δ immunodeficiencies

    Journal of Experimental Medicine, Vol. 204, Núm. 11, pp. 2537-2544